Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1997 Jul;226(1):66–69. doi: 10.1097/00000658-199707000-00009

Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer.

T J Farrell 1, D J Barbot 1, F E Rosato 1
PMCID: PMC1190908  PMID: 9242339

Abstract

OBJECTIVE: The objective of the study was to analyze a single center's experience in the treatment of pancreatic carcinoma with a combination of pancreatic resection and intraoperative radiation therapy (IORT). SUMMARY BACKGROUND DATA: Pancreatic cancer is the most lethal form of gastrointestinal malignancy. Historically, it carries a 20% 1-year survival and a 5-year survival of 3% to 5%. Since 1987, patients at Thomas Jefferson University Hospital have been offered IORT in an attempt to improve their survival. METHODS: The authors reviewed all patients treated at Thomas Jefferson University Hospital with pancreatic adenocarcinoma from 1987 to 1994. From this population, 14 patients were identified who received IORT in conjunction with curative surgery. Duration of hospital stay, perioperative complications, duration of postoperative ileus, and survival were assessed by retrospective review. RESULTS: Of the 14 patients, 6 were male and 8 were female. Patient median age was 61. Six patients had stage I disease, 2 had stage II, 6 had stage III. Two patients had total pancreatectomy, 2 had distal pancreatectomy, and the remaining had pancreaticoduodenectomy (Whipple resection). Median survival was 16 months with a 15.5% 5-year survival. Postoperative complications, duration of hospital stay, and duration of postoperative ileus were not adversely affected by the addition of IORT when compared to in-house control subjects. CONCLUSIONS: Intraoperative radiation therapy is a useful adjunct to surgical resection as treatment of pancreatic cancer. The authors' data suggested it can prolong median survival and long-term survival without adding significant morbidity.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Evans D. B., Termuhlen P. M., Byrd D. R., Ames F. C., Ochran T. G., Rich T. A. Intraoperative radiation therapy following pancreaticoduodenectomy. Ann Surg. 1993 Jul;218(1):54–60. doi: 10.1097/00000658-199307000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Griffin J. F., Smalley S. R., Jewell W., Paradelo J. C., Reymond R. D., Hassanein R. E., Evans R. G. Patterns of failure after curative resection of pancreatic carcinoma. Cancer. 1990 Jul 1;66(1):56–61. doi: 10.1002/1097-0142(19900701)66:1<56::aid-cncr2820660112>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  3. Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer. 1987 Nov 1;60(9):2284–2303. doi: 10.1002/1097-0142(19871101)60:9<2284::aid-cncr2820600930>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  4. Jessup J. M., Posner M., Huberman M. Influence of multimodality therapy on the management of pancreas carcinoma. Semin Surg Oncol. 1993 Jan-Feb;9(1):27–32. doi: 10.1002/ssu.2980090106. [DOI] [PubMed] [Google Scholar]
  5. Kawamura M., Kataoka M., Fujii T., Itoh H., Ishine M., Hamamoto K., Yokoyama S., Takashima S., Satoh M., Inoue K. Electron beam intraoperative radiation therapy (EBIORT) for localized pancreatic carcinoma. Int J Radiat Oncol Biol Phys. 1992;23(4):751–757. doi: 10.1016/0360-3016(92)90648-2. [DOI] [PubMed] [Google Scholar]
  6. Moertel C. G., Frytak S., Hahn R. G., O'Connell M. J., Reitemeier R. J., Rubin J., Schutt A. J., Weiland L. H., Childs D. S., Holbrook M. A. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer. 1981 Oct 15;48(8):1705–1710. doi: 10.1002/1097-0142(19811015)48:8<1705::aid-cncr2820480803>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  7. Mohiuddin M., Rosato F., Barbot D., Schuricht A., Biermann W., Cantor R. Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 1992;23(2):305–311. doi: 10.1016/0360-3016(92)90746-5. [DOI] [PubMed] [Google Scholar]
  8. Warshaw A. L., Fernández-del Castillo C. Pancreatic carcinoma. N Engl J Med. 1992 Feb 13;326(7):455–465. doi: 10.1056/NEJM199202133260706. [DOI] [PubMed] [Google Scholar]
  9. Wu H. S., Little A. G. Perioperative blood transfusions and cancer recurrence. J Clin Oncol. 1988 Aug;6(8):1348–1354. doi: 10.1200/JCO.1988.6.8.1348. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES